vs
Side-by-side financial comparison of Beam Global (BEEM) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($17.3M vs $9.0M, roughly 1.9× Beam Global). ROCKWELL MEDICAL, INC. runs the higher net margin — -9.2% vs -25.8%, a 16.5% gap on every dollar of revenue. On growth, Beam Global posted the faster year-over-year revenue change (6.7% vs -8.5%). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-18.2% CAGR vs -21.2%).
Suntory Global Spirits Inc., formerly known as Beam Suntory, Inc., and before that as Beam, Inc., is an American beverage company that is a subsidiary of Suntory Holdings, a Japanese multinational beverage conglomerate. The company produces alcoholic beverages.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
BEEM vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.0M | $17.3M |
| Net Profit | $-2.3M | $-1.6M |
| Gross Margin | 17.8% | 16.8% |
| Operating Margin | -29.3% | — |
| Net Margin | -25.8% | -9.2% |
| Revenue YoY | 6.7% | -8.5% |
| Net Profit YoY | 49.6% | — |
| EPS (diluted) | — | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $17.3M | ||
| Q4 25 | $9.0M | $18.3M | ||
| Q3 25 | $5.8M | $15.9M | ||
| Q2 25 | $7.1M | $16.1M | ||
| Q1 25 | $6.3M | $18.9M | ||
| Q4 24 | $8.5M | $24.7M | ||
| Q3 24 | $11.5M | $28.3M | ||
| Q2 24 | $14.8M | $25.8M |
| Q1 26 | — | $-1.6M | ||
| Q4 25 | $-2.3M | $-554.0K | ||
| Q3 25 | $-4.9M | $-1.8M | ||
| Q2 25 | $-4.3M | $-1.5M | ||
| Q1 25 | $-15.5M | $-1.5M | ||
| Q4 24 | $-4.6M | $-756.0K | ||
| Q3 24 | $1.3M | $1.7M | ||
| Q2 24 | $-4.9M | $343.0K |
| Q1 26 | — | 16.8% | ||
| Q4 25 | 17.8% | 21.1% | ||
| Q3 25 | -0.5% | 14.3% | ||
| Q2 25 | 20.3% | 15.6% | ||
| Q1 25 | 7.9% | 16.1% | ||
| Q4 24 | 26.3% | 14.7% | ||
| Q3 24 | 10.7% | 22.0% | ||
| Q2 24 | 15.9% | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | -29.3% | -2.2% | ||
| Q3 25 | -84.2% | -9.9% | ||
| Q2 25 | -63.1% | -8.4% | ||
| Q1 25 | -245.8% | -7.2% | ||
| Q4 24 | -60.1% | -2.1% | ||
| Q3 24 | 11.2% | 6.8% | ||
| Q2 24 | -32.3% | 2.0% |
| Q1 26 | — | -9.2% | ||
| Q4 25 | -25.8% | -3.0% | ||
| Q3 25 | -84.1% | -11.0% | ||
| Q2 25 | -60.5% | -9.3% | ||
| Q1 25 | -245.5% | -8.0% | ||
| Q4 24 | -54.5% | -3.1% | ||
| Q3 24 | 11.3% | 5.9% | ||
| Q2 24 | -33.2% | 1.3% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.28 | $-0.05 | ||
| Q2 25 | $-0.28 | $-0.05 | ||
| Q1 25 | $-1.04 | $-0.04 | ||
| Q4 24 | $-0.31 | $-0.02 | ||
| Q3 24 | $0.09 | $0.04 | ||
| Q2 24 | $-0.34 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $969.0K | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $24.8M | $35.9M |
| Total Assets | $42.7M | $57.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $969.0K | $10.7M | ||
| Q3 25 | $3.3M | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $4.6M | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M |
| Q1 26 | — | $35.9M | ||
| Q4 25 | $24.8M | $37.0M | ||
| Q3 25 | $26.5M | $37.0M | ||
| Q2 25 | $26.9M | $30.4M | ||
| Q1 25 | $26.7M | $31.5M | ||
| Q4 24 | $41.3M | $32.6M | ||
| Q3 24 | $46.4M | $29.1M | ||
| Q2 24 | $43.4M | $23.5M |
| Q1 26 | — | $57.4M | ||
| Q4 25 | $42.7M | $57.1M | ||
| Q3 25 | $44.6M | $57.5M | ||
| Q2 25 | $46.7M | $52.6M | ||
| Q1 25 | $46.8M | $54.0M | ||
| Q4 24 | $61.5M | $59.2M | ||
| Q3 24 | $67.3M | $57.1M | ||
| Q2 24 | $71.9M | $53.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | — |
| Free Cash FlowOCF − Capex | $-3.8M | — |
| FCF MarginFCF / Revenue | -42.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-3.8M | $2.3M | ||
| Q3 25 | $-4.6M | $-1.3M | ||
| Q2 25 | $-318.0K | $1.8M | ||
| Q1 25 | $-1.8M | $-3.5M | ||
| Q4 24 | $859.0K | $865.0K | ||
| Q3 24 | $-3.0M | $4.3M | ||
| Q2 24 | $2.9M | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-3.8M | $2.2M | ||
| Q3 25 | $-5.1M | $-1.5M | ||
| Q2 25 | $-1.1M | $1.7M | ||
| Q1 25 | $-1.8M | $-3.5M | ||
| Q4 24 | $462.0K | $470.0K | ||
| Q3 24 | $-3.1M | $4.1M | ||
| Q2 24 | $2.8M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | -42.3% | 12.0% | ||
| Q3 25 | -87.9% | -9.6% | ||
| Q2 25 | -15.2% | 10.5% | ||
| Q1 25 | -28.7% | -18.8% | ||
| Q4 24 | 5.4% | 1.9% | ||
| Q3 24 | -27.4% | 14.4% | ||
| Q2 24 | 18.9% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 7.8% | 1.4% | ||
| Q2 25 | 10.7% | 1.0% | ||
| Q1 25 | 0.9% | 0.3% | ||
| Q4 24 | 4.7% | 1.6% | ||
| Q3 24 | 1.7% | 0.7% | ||
| Q2 24 | 0.9% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.28× | 2.57× | ||
| Q2 24 | — | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BEEM
| Products | $7.0M | 77% |
| Other | $2.0M | 23% |
RMTI
Segment breakdown not available.
